|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 314.95 DKK | +1.27% |
|
-14.37% | -3.17% |
| 02-11 | Meijer announces new affordable access to GLP-1 medications | RE |
| 02-10 | Deutsche Bank Lowers Price Target for Novo Nordisk to 400 Danish Kroner (475), Reiterates Buy | FW |
| Capitalization | 1,399B 223B 187B 171B 163B 302B 20,189B 315B 1,983B 790B 9,727B 836B 819B 34,377B | P/E ratio 2026 * |
15.1x | P/E ratio 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise value | 1,496B 238B 200B 183B 174B 323B 21,582B 337B 2,120B 844B 10,398B 894B 875B 36,749B | EV / Sales 2026 * |
5.14x | EV / Sales 2027 * | 4.82x |
| Free-Float |
70.25% | Yield 2026 * |
3.43% | Yield 2027 * | 3.66% |
Last Transcript: Novo Nordisk A/S
| 1 day | +1.27% | ||
| 1 week | -14.37% | ||
| Current month | -14.77% | ||
| 1 month | -17.43% | ||
| 3 months | +6.87% | ||
| 6 months | -2.51% | ||
| Current year | -3.17% |
| 1 week | 272.9 |  | 321.95 |
| 1 month | 272.9 | | 409.95 |
| Current year | 272.9 | | 409.95 |
| 1 year | 266.9 | | 675.2 |
| 3 years | 266.9 | | 1,033.2 |
| 5 years | 210.08 | | 1,033.2 |
| 10 years | 109.1 | | 1,033.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 07/08/2025 | |
| Director of Finance/CFO | 55 | 15/02/2018 | |
Martin Lange
CTO | Chief Tech/Sci/R&D Officer | 56 | 07/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kasim Kutay
BRD | Director/Board Member | 61 | 23/03/2017 |
| Director/Board Member | 51 | 22/03/2018 | |
| Director/Board Member | 61 | 24/03/2022 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.32% | 21.31% | 1,387 M€ | |
| +5.35% | 10.45% | 4 M€ | |
| +1.18% | 5.4% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.27% | -14.37% | -48.82% | -34.95% | 223B | |
| -1.88% | +2.15% | +17.97% | +197.00% | 918B | |
| -0.12% | +2.25% | +54.53% | +46.99% | 574B | |
| -0.37% | -1.43% | +16.86% | +46.29% | 393B | |
| -0.76% | -0.40% | +20.82% | +25.33% | 366B | |
| +0.67% | +3.52% | +24.82% | +51.69% | 301B | |
| +1.99% | +2.52% | +20.87% | +24.35% | 300B | |
| -0.42% | +1.13% | +35.59% | +7.90% | 291B | |
| -2.97% | +7.70% | +23.70% | +50.37% | 196B | |
| -2.93% | +2.76% | +54.20% | +69.82% | 183B | |
| Average | -0.55% | +0.96% | +22.05% | +48.48% | 374.54B | |
| Weighted average by Cap. | -0.63% | +1.32% | +23.98% | +73.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 291B 46.32B 38.93B 35.49B 33.89B 62.71B 4,195B 65.51B 412B 164B 2,021B 174B 170B 7,143B | 307B 48.94B 41.12B 37.49B 35.8B 66.25B 4,432B 69.21B 435B 173B 2,135B 184B 180B 7,546B |
| Net income | 92.45B 14.73B 12.38B 11.28B 10.78B 19.94B 1,334B 20.83B 131B 52.19B 643B 55.25B 54.1B 2,271B | 98.01B 15.61B 13.12B 11.96B 11.42B 21.14B 1,414B 22.08B 139B 55.33B 681B 58.57B 57.36B 2,408B |
| Net Debt | 96.56B 15.38B 12.93B 11.79B 11.25B 20.83B 1,393B 21.76B 137B 54.51B 671B 57.7B 56.51B 2,372B | 82.49B 13.14B 11.04B 10.07B 9.61B 17.79B 1,190B 18.58B 117B 46.56B 573B 49.29B 48.27B 2,026B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/02/26 | 314.95 kr | +1.27% | 6,654,129 |
| 09/02/26 | 311.00 kr | +5.25% | 13,447,170 |
| 06/02/26 | 295.50 kr | +5.29% | 13,243,370 |
| 05/02/26 | 280.65 kr | -7.88% | 24,226,390 |
| 04/02/26 | 304.65 kr | -17.17% | 35,894,110 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition